nava in ards - critical care canada forum · 2019. 9. 27. · nava in ards antonio pesenti...
TRANSCRIPT
NAVA IN ARDS
Antonio [email protected]
Dip.di Medicina Sperimentale
Università Milano-Bicocca
Osp. S. Gerardo, Monza
ISICEM 2012 - 8
Conflicts of Interest
• Maquet: Received research support and consultation fees
• Drager: Received research support and consultation fees
• GE: Received research support and consultation fees
• Patents on CO2 removal by acidification (University of Milan Bicocca)
Control signals for mechanical ventilation in spontaneously breathing patients
Sinderby et al Nature Medicine 1999
-8
8
0
25
0
0
500
-0.8
0.8
0
Pel,cw
PTPpes
Ti
Flo
w
(l/s
)
Vol
(ml)
Paw
(cm
H2O
)
Pes
(cm
H2O
)The Pressure-Time Product (PTP)
Mechanical WOB Pressure Time Product
PTP is a very good indicator of O2
muscle consumptionField et al J appl Phyisiol 1984
LINEAR RELATIONSHIP BETWEEN Eadi AND Pmusc
Average EAdi (µV,±2s.e.)
0 2 4 6 8 10 12 14 16 18Ave
rag
e P
Mu
sc (
cm
H2O
±2
s.e
.)
0
2
4
6
8
10
12
Assessing the relationship betweenPmusc and EAdi
Bellani G. et al. submitted
PEI measurement without esophagealpressure
PEIdyn (cmH2O/µV)
0,0 0,5 1,0 1,5 2,0
PE
I occl (cmH2O/µV)
0,0
0,5
1,0
1,5
2,0
2,5
3,0
PEIoccl is a good surrogate of PEIdyn
PEIoccl * Eadi allows to estimate Pmusc
Conclusion
• Diaphragmatci monitoring should become a routinely in patients undergoing spontaneousassisted breathing
• Ultrasound appears promising for «one-shot» assessment
• New tools available for continuous monitoringof the electrical activity of the diaphragm, which can be transalated into pressure
PSV Trial
SUCCESSES
38
FAILURES
10
48 Pts.
Cereda M et al. Crit Care Med. 2000
PSV failures
higher PaCO2 and VElower compliance
during CPPV
Cereda M et al. Crit Care Med. 2000
AirwaysFlow
Airwayspressure
Volume
Edi
0
0
0
0
35
1400
400
20
SEVERE ARDS, Crs=10, PSV
NAVA and (A)SYNCHRONY:EXPIRATORY MATCHING
PATRONITI N et al. unpublished
AirwaysFlow
Airwayspressure
Volume
Edi
0
0
0
35
1400
400
20
SEVERE ARDS, Crs=10, NAVA
NAVA and (A)SYNCHRONY:EXPIRATORY MATCHING
PATRONITI N et al. unpublished
NAVA vs PSV DURING ECMO
• We studied 10 severe ARDS patients.
• Patients were 46 ± 13 year-old and 3 were females.
• Crs was 18 ± 8 (range 7-31) mL/cmH20 with PEEP 9 ± 4 cmH20.
• Nine patients were undergoing v-v ECMO and one v-a ECMO with 3.2 ± 0.5 L/min blood flow, which granted 47 ± 17% of total O2consumption
• MV days were 23 ± 17 and ECMO days 19 ± 14.
MAURI T. et al. submitted
NAVA vs PSV DURING ECMO• We tested for 30’ (random order):
1. PSV with expiration cycling time = 30% of flow peak value(PSV30);
2. PSV with cycling time = 1% (PSV1);3. NAVA.
• PEEP, FiO2 and ECMO setting were left unchanged. PSVsupport and NAVA gain levels were chosen to leave tidalvolume (VT) unchanged.
• We measured asynchrony index (AI) = number of asynchronyevents/total respiratory rate (ventilator cycles + wastedefforts) × 100
MAURI T. et al. submitted
NAVA vs PSV DURING ECMO
MAURI T. et al. submitted
NAVA vs PSV DURING ECMO
MAURI T. et al. submitted
NAVA vs PSV DURING ECMO
• Our data indicate that NAVA may ameliorate patient-ventilator interaction and decrease respiratory distress in severe ARDS patients undergoing ECMO.
• NAVA effects are more evident in sicker ptswith extremely low Crs values
MAURI T. et al. submitted
Colombo D
Flo
w (
ml/s)
-1500
-1000
-500
0
500
1000
1500
Airw
ay p
ressu
re (
cm
H2
O)
0
10
20
30
40
Vo
lum
e (
ml)
0
200
400
600
800
1000
Time (s)
0 2 4 6 8 10 12 14 16 18 20
Ele
ctr
. D
iap
hr.
act
(V
)
0
8
16
24
32
Flo
w (
ml/s)
-600
-400
-200
0
200
400
600
800
Airw
ay p
ressu
re (
cm
H2
O)
0
2
4
6
8
10
12
14
16
Vo
lum
e (
ml)
0
100
200
300
400
500
Time (s)
0 2 4 6 8 10 12 14 16 18 20
Ele
ctr
. D
iap
hr.
act (
V)
0
1
2
3
4
5
6
7
Pressure Support NAVA
NAVA vs PSV in ARDS
• EaDI has intrinsic variability in Both NAVA and PSV modes
• Nava reflects EaDI variability in TV variability
• PSV does not
Conclusion (s)
Spontaneous breathing does have a role in ARDS
PSV: SOME limitations (low cpl)
NAVA improves synchrony, maintainsoxygenation, protective Vts
Why would NAVA improve oxygenation?